News for Healthier Living
Study Suggests Higher Risk of CV Events When Initiating Denosumab for Osteoporosis in Dialysis Patients
An observational study emulated a target trial to determine the risk for major adverse cardiovascular events (MACE) and fracture prevention effects with denosumab versus bisphosphonates in dialysis-dependent patients.
January 6, 2025
January 8 2025January 7 2025January 6 2025January 4 2025January 3 2025January 2 2025January 1 2025December 31 2024December 30 2024December 29 2024December 28 2024December 27 2024December 26 2024
|
|
|
|
|